Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death  by Elsässer, Albrecht et al.
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OBJECTIVES The aim of the present study was to objectify the loss of myocytes and the mechanism by
which myocytes die in human hibernating myocardium (HHM).
BACKGROUND Intracellular degeneration, reduced cellular protein synthesis, and the replacement fibrosis
contribute to structural disintegration of HHM.
METHODS In 14 patients, HHM was diagnosed by dobutamine echocardiography, radionuclide
ventriculography, and thallium-201 scintigraphy. Functional recovery was documented by
repeating the preoperative clinical investigations three months after successful coronary artery
bypass graft surgery (CABG). During CABG, transmural biopsies were taken from the center
of HHM regions and studied by electron microscopy, immunohistochemistry, the terminal
deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) method, reverse
transcription-polymerase chain reaction, and Western blotting. Control samples were taken
from nondiseased human myocardium.
RESULTS All patients showed significant improvement or normalization of the regional function of
HHM. Ubiquitin-related autophagic cell death was evident ultrastructurally by the occur-
rence of autophagic vacuoles, cellular degeneration, and nuclear disassembly. Ubiquitin-
protein complexes were found in 0.03  0.008% (control: 0%, p  0.005) of all myocytes.
The proteasome 20S subunit/total myocytes were reduced from 63.3  9.6% in control
myocardium to 36.9 8.4% in HHM. Complement-9, indicating oncosis, was found in only
one of 14 biopsies. TUNEL-positive myocytes were 0.002  0.0003%. Electron microscopy
showed apoptotic cells in 3 of 14 samples. However, the bcl-2/bax ratio was significantly
reduced. Moreover, caspase-3 messenger ribonucleic acid was 8.5 times upregulated, and
caspase-3 was activated. Cell death was absent in controls.
CONCLUSIONS In HHM, ubiquitin-related autophagic cell death and apoptosis cause a loss of myocytes. This
plays an important role in progressive tissue damage and causes a reduction of the extent of
functional recovery of HHM. (J Am Coll Cardiol 2004;43:2191–9) © 2004 by the
American College of Cardiology Foundationa
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un his seminal studies, Rahimtoola (1) defined hibernating
yocardium as a state of persistently impaired myocardial
ontractile function at rest due to reduced coronary blood
ow. Despite this myocardial undersupply, however, adap-
ations of myocardial energy metabolism and function (e.g.,
n increase in glycolytic adenosine triphosphate [ATP]
ormation and a reduction in ATP consumption by atten-
ated contractile performance) aid in decreasing the isch-
mic myocardial energy deficit (2,3). In contrast to chronic
uman hibernation, short-term hibernation is defined as sus-
ained perfusion-contraction matching for several hours, as
emonstrated in experimental studies. Furthermore, short-
erm hibernation is characterized by a lack of necrosis, com-
lete functional recovery during reperfusion, and recovery of
etabolic parameters during persistent ischemia, whereas in
uman hibernating myocardium (HHM), a complete restora-
ion of the energetic situation cannot be achieved (3).
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ent of Cardiology, Ruprecht-Carls-University, Heidelberg; ‡Department of Exper-
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nd cellular adaptations observed in HHM might delay and
lleviate ischemic myocardial injury, there is increasing evi-
ence that ongoing myocyte degeneration, reduced cellular
rotein synthesis, and an increased rate of synthesis of replace-
ent fibrosis finally cause irreversible myocardial disintegra-
ion, limiting the structural and functional recovery after
evascularization. Our group has shown that in HHM the
umber of myocytes is reduced, and replacement fibrosis
evelops with increasing duration and severity of ischemia (4).
owever, it has not yet been clarified by which mechanism
yocytes die in HHM. Therefore, the aim of the present study
as to identify the type of cell death occurring in HHM.
Three different types of cell death might be responsible
or the disappearance of myocytes: apoptosis, ubiquitin-
elated autophagic cell death, and oncosis (necrosis). Onco-
is is independent of energy supply and caspase activity.
poptosis and autophagic cell death are actively pro-
rammed, energy-dependent phenomena, but apoptosis is
aspase-dependent and autophagy is caspase-independent.
poptosis has been described to occur at various rates in
schemic or failing myocardium, but its importance is still
nder discussion (5). Autophagic cell death has been de-
cribed in hypertrophied and failing myocardium (6,7). It
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Cell Death in HHM June 16, 2004:2191–9nvolves post-translational modification of proteins by link-
ge to numerous ubiquitin molecules in preparation for
egradation by proteasomal enzymes. Excessive storage of
olyubiquinated protein complexes leads to a loss of cell
uclei and cell death (8). From the present study, it is
oncluded that myocyte cell death is an unfavorable prog-
ostic finding, indicating that HHM is at risk of irreversible
issue damage and a loss of functional capacity.
ETHODS
atients and study protocol. Fourteen patients with cor-
nary heart disease and reduced left ventricular (LV) func-
ion were included in the study. As described previously,
fter angiographic diagnostics, which resulted in the indi-
ation for coronary artery bypass graft surgery (CABG), the
educed global and regional ejection fractions were verified
y radionuclide ventriculography (4,9). Tissue ischemia and
yocardial viability were assessed by thallium-201 scintig-
aphy using a stress-rest reinjection protocol. Echocardiog-
aphy with low-dose dobutamine showed the extent of
unctional capacity of the afflicted regions.
All patients underwent revascularization of the hibernat-
ng area by CABG. The patients were restudied three
onths after revascularization by all methods employed
reoperatively in order to determine the degree of functional
ecovery after restitution of adequate myocardial perfusion
Table 1).
Informed, written consent from all patients for each
nvestigation, as well as approval by the hospital’s Institu-
ional Review Board of the University of Freiburg, had been
btained.
linical methods. DOBUTAMINE TWO-DIMENSIONAL
CHOCARDIOGRAPHY. Transthoracic echocardiographic
tudies were performed at rest and during intravenous
nfusion of dobutamine at a rate of 5 and 10 g/kg body
eight/minute (each dosage given over 10 min). According
o the recommendations of the American Society of Echo-
ardiography, regional function was evaluated in images of
tandard views using a scoring system (1  normal; 2 
lightly hypokinetic; 3  severely hypokinetic; 4  akinetic;
Abbreviations and Acronyms
ATP  adenosine triphosphate
CABG  coronary artery bypass graft surgery
DNA  deoxyribonucleic acid
HHM  human hibernating myocardium
LV  left ventricle/ventricular
RNA  ribonucleic acid
RT-PCR  reverse transcription-polymerase chain
reaction
SPECT  single-photon emission computed
tomography
TUNEL  terminal deoxynucleotidyl transferase-
mediated nick end-labeling dyskinetic) (10). Wall motion score indexes for global T 1 1 1 1 1 A w
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June 16, 2004:2191–9 Cell Death in HHMLV) function and for the hibernating areas were calculated
t rest and during dobutamine infusion.
HALLIUM-201 SCINTIGRAPHY. A stress-rest reinjection
rotocol was used. At peak exercise testing, a dose of 111
Bq was injected intravenously. Four hours after exercise,
edistribution images were acquired, followed by the admin-
stration of an additional thallium dose (37 MBq) at rest.
einjection images were documented 30 min thereafter.
he data obtained by myocardial single-photon emission
omputed tomography (SPECT) were reoriented into ver-
ical long-axis, short-axis, and horizontal long-axis slices,
sing the Wiener filter for the entire LV. The SPECT
mages were analyzed qualitatively in 13 sectors, as well as
uantitatively for four representative tomograms, using the
ircumferential profile analysis, and were compared with the
atabase of a reference population (probability 5% for
ignificant coronary artery disease; 46 women and 38 men
nvestigated at our center).
In the qualitative analysis, regional tracer activity of a
tress defect and the extent of its redistribution on reinjec-
ion images were interpreted visually as completely revers-
ble, incompletely reversible, or fixed defects. Quantitatively,
hallium uptake on stress images 2 SD of the mean value
n the reference population was classified as abnormal, and
n increase in segmental uptake by 15% or more, as
easured on reinjection images, was considered “reversible”
n the baseline study.
Preoperatively, myocardial perfusion was estimated by
omparing the lowest thallium uptake value in the hiber-
ating area after reinjection with those values in the data-
ase of our reference population.
The four tomograms were subdivided into three descrip-
or territories with respect to the perfusion areas of the three
ain coronary vessels.
According to the confidence interval (2 SD) of our
eference population, a peak myocardial thallium uptake of
5% or more indicated unimpaired perfusion.
ADIONUCLIDE VENTRICULOGRAPHY. Using a dose of 740
Bq of technetium-99m–labeled in vivo red blood cells,
esting and exercise LV wall motion was assessed by
ultigated radionuclide ventriculography. Calculation of
egional and global ejection fraction was performed by
rawing nine radii to the LV border dividing the ventricle
nto an equal number of sectors.
ORONARY ANGIOGRAPHY. Coronary narrowing was doc-
mented in multiple projections and was assessed as the
ercentage of diameter stenosis. Left ventriculography was
erformed in the biplane view.
omparison of the different methods. For comparison, all
V segments were grouped into three vascular territories:
he anterior and anterolateral wall was seen as the perfusion
rea of the left anterior descending coronary artery; the
ateral LV wall was related to the left circumflex artery; and
he inferior and posterior walls were allocated to the right floronary artery. The final assignment was adapted accord-
ng to the findings of coronary angiography, especially for
he inferior wall and the apex.
For the unequivocal diagnosis of HHM, all of the
ollowing criteria had to be fulfilled:
. Echocardiography: improvement of regional function in
at least two adjacent abnormal segments by a factor 1
of the scoring system during dobutamine infusion on the
baseline study and postoperatively at rest.
. Thallium-201 scintigraphy: reversibility of a defect
and/or uptake value in the range of the mean normal
uptake 2 SD on the baseline study, as well as absent
signs of ischemia or infarction and a normalization of the
uptake values after revascularization.
. Radionuclide ventriculography: postoperative improve-
ment of the preoperatively impaired regional ejection
fraction by at least 5%.
. Coronary angiography: documentation of adequate re-
vascularization by bypass grafts.
he study population fulfilled all criteria listed. Concor-
ance of the diagnostic results of the different clinical
ethods in the baseline study and postoperative normaliza-
ion of regional function ensure that the myocardial biopsies
ere representative of HHM.
ISSUE SAMPLING. During open-heart surgery, two trans-
ural biopsies (cylinders of about 1 mm diameter, weighing
to 15 mg) from each patient were taken from the center of
he area clinically defined as HHM. The tissue was either
mmediately fixed in buffered glutaraldehyde for electron
icroscopy or immersed in liquid nitrogen for immuno-
istochemistry, Western blotting, reverse transcription-
olymerase chain reaction (RT-PCR), and the terminal
eoxynucleotidyl transferase-mediated nick end-labeling
TUNEL) method.
LECTRON MICROSCOPY. Small tissue samples were em-
edded in Epon after routine procedures. Ultrathin sections
ere viewed and photographed in a Philips CM 10 electron
icroscope.
MMUNOHISTOCHEMISTRY. Cryosections were fixed
ith 4% paraformaldehyde. The sections were incubated
ith the first antibody (rabbit-ubiquitin [Dako, Cam-
ridgeshire, United Kingdom], anti-mouse 20S proteasome
ubunit 5 [Biotrend, Ko¨ln, Germany], and mouse
omplement-9 [C9; Novo Castra, New Castle, United
ingdom]), followed by treatment with a secondary biotin-
lated detection system using either anti-mouse or anti-
abbit immunoglobulins. The last incubation was carried
ut with fluoroisothiocyanate-linked streptavidin (Amer-
ham, Braunschweig, Germany). The sections were viewed
n a confocal laser microscope (Leica, Solms, Germany).
UNEL. TUNEL was performed on cryosections with an in
itu cell detection kit (Roche, Basel, Switzerland) using
uorescein labeling.
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Cell Death in HHM June 16, 2004:2191–9ORPHOMETRY. Myocytes labeled for either TUNEL,
biquitin, or C9 were quantified by counting the entire
rea of five tissue sections (diameter 1 mm) obtained at
ifferent levels from each biopsy. In ubiquitin-labeled
ections, only myocytes with large ubiquitin-protein
omplexes lacking a nucleus were counted. All positive
ells were expressed as the percentage of the total number
f myocytes evaluated (280 to 350 per tissue section, total
bout 1,500).
ESTERN BLOTTING. Sodium dodecyl sulfate-polyacrylamide
el electrophoresis and immunoblotting were performed in
ix control and 14 HHM samples. Antibodies included
abbit bcl-2 (Santa Cruz, California), rabbit bcl-xL (Santa
ruz), rabbit bax (Santa Cruz), rabbit-cleaved casp-3
Pharmingen, San Diego, California), mouse p53 (Calbio-
hem, San Diego, California), and rabbit c-myc (Santa
ruz). Quantitation was done by scanning of the immuno-
lots on a STORM 860 (Amersham-Pharmacia-Biotech).
T-PCR. Total ribonucleic acid (RNA) of HHM was iso-
ated using the guanidinium acid phenol-chloroform extrac-
ion method. First, strand synthesis of total RNA was
erformed using ingredients corresponding to standardized
rotocols. Reverse transcription was carried out at 42°C,
ollowed by incubation at 95°C, to stop the reaction.
The PCR reactions were performed in duplicate with 60
g of complementary deoxyribonucleic acid (cDNA), using
Perkin Elmar Gene Amp 9700. Primers were as follows:
cl-2 human: base pair (bp) 395-cn 32-ant 65; bcl-xL: bp
63-cn 32-ant 60; bax human: bp 358-cn 32-ant 60; casp-3
uman: bp 833-cn 37-ant 55; p53 human: bp 330-cn 31-ant
0; c-myc human: bp 402-cn 31-ant 64; and GAPDH
uman: bp 496-cn 24-ant 60.
For quantitative analysis, the amplification products were
eparated on 2% agarose gel, stained with ethidium bro-
ide, visualized by ultraviolet irradiation, and photo-
raphed with Polaroid film 667, evaluating the band den-
ities by volume integration (Image Quant, Molecular
ynamics, Freiburg, Germany). GAPDH served as an
nternal control for the calculation of densitometric results.
ONTROL TISSUE. Biopsies from three patients undergoing
perative correction of atrial septal defects and three donor
earts not used for transplantation served as controls.
tatistical analysis. Data are presented as the mean value
SE. To evaluate the clinical data, the Friedman and
unn test, analysis of variance, Bonferroni test, unpaired t
est, and Mann-Whitney rank-sum test were used for
chocardiography and radionuclide ventriculography, and
he Wilcoxon test, paired t test, and Mann-Whitney rank-
um test were used for thallium-201 scintigraphy. Analysis
f variance and Bonferroni testing were used to analyze the
orphologic data, Western blotting, and RT-PCR results.
value p  5% was considered to represent a significantifference. cESULTS
linical Results
chocardiography. The preoperative mean value of the
all motion score index of the hibernating regions de-
reased from 3.9  0.1 to 1.1  0.3 at rest postoperatively
p  0.05). The extent of functional recovery was predicted
y dobutamine infusion in the baseline study (1.2  0.4)
preoperative/postoperative: p  0.05; preoperative dobut-
mine/postoperative: p  NS) (Table 1).
adionuclide ventriculography. Postoperative normaliza-
ion of the regional function of HHM, depressed preoper-
tively, occurred (preoperative/postoperative: 26.6  5.1%/
1.3  3.9%; p  0.05) (Table 1).
hallium-201 scintigraphy. Preoperatively, 67 of total
82 segments were classified as HHM by qualitative and
uantitative analysis of the reinjection images. Three
onths after revascularization, all of the segments showed
egular tracer uptake and distribution, without signs of
schemia or infarction on the stress-redistribution reinjec-
ion images. The values of thallium-201 uptake increased
rom 38.5  1.5% in HHM preoperatively to 65.7  2.0%
hree months postoperatively, indicating normal perfusion.
oronary angiography. The degree of coronary artery
tenosis supplying the hibernating regions varied between
5% and 100%. Postoperatively, an adequate revasculariza-
ion was evident (Table 1).
issue Analysis
lectron microscopy. Numerous myocytes in HHM
howed signs of degeneration, such as a lack of contractile
aterial, as well as nuclear and mitochondrial changes, as
escribed earlier (4). Degenerative material (i.e., either
otally empty or lipid-filled vacuoles, myelin figures, and
ipofuscin) and numerous autophagic vacuoles and the
bsence of nuclei indicated development of autophagic cell
eath (Fig. 1A).
The expanded extracellular space contained large
mounts of fibrotic material, including collagen fibrils,
ipofuscin-containing macrophages, and electron dense
ground substance” representing fibronectin, laminin, and
he proteoglycans (Fig. 1B). These degenerative changes
ere absent in nondiseased control myocardium.
Evidence of apoptosis in single myocytes was found in
hree biopsies. Typical morphologic signs of apoptosis
ncluded: intact mitochondria and intact sarcolemma, nuclei
f varying size and shape (showing distinct chromatin
lumping), and formation of apoptotic bodies, which indi-
ate nuclear disassembly (Fig. 1C). Due to sequestration of
ellular particles from myocytes, the size and shape of
poptotic cells varied greatly. This cellular debris was
mbedded in the extracellular matrix or was engulfed by
acrophages. Evidence of acute cell death (oncosis) was not
ound. Mitotic figures were never observed.
mmunohistochemistry. UBIQUITIN. Ubiquitin-positive
ells showed either a small punctate-labeling pattern or
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June 16, 2004:2191–9 Cell Death in HHMxhibited large accumulations of ubiquitin-protein com-
lexes (Fig. 2). In control myocardium, ubiquitin was
bsent; in HHM, 0.03  0.008% of all myocytes were
abeled.
OMPLEMENT-9. Complement-9 was found in single myo-
ytes in HHM in only one of 14 biopsies (Fig. 3).
ROTEASOME 20S SUBUNIT. In control myocardium, 63.3
.6% of all nuclei were labeled. In HHM, this was reduced
o 36.9  8.4% (p  0.01) (Fig. 4).
I-67. In HHM and controls, about one myocyte nucleus
er 1,000 showed positive labeling.
UNEL. Single TUNEL-positive myocytes were found in
of 14 patients, resulting in an apoptotic rate of 0.002 
.0003% (Fig. 5). In control myocardium, apoptosis was
bsent.
igure 2. Large ubiquitin-protein complexes (green) in myocytes (red)
acking a nucleus in the confocal microscope. Nuclei are stained blue
TOTO). Bar  10 m.
igure 3. One myocyte is clearly labeled for complement-9 (green) in the
onfocal microscope. All other myocytes are counterstained with phalloidinigure 1. Electron microscopic images of human hibernating myocardium
HHM). (A) Degenerative changes with numerous autophagic vacuoles
AV) and a lack of nucleus, indicating autophagic cell death. (B) Widening
f the interstitial space that contains fibroblasts (F), macrophages (small
rrows), and cellular debris (CB). Note the lack of contractile material in
ne myocyte (arrow). (C) Apoptotic nuclear disassembly in a myocyte
thick arrows). Note the formation of an apoptotic body (thin arrows). All
ars  5 m. red); nuclei are blue (TOTO). Bar  20 m.
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Cell Death in HHM June 16, 2004:2191–9estern blotting and RT-PCR. CASPASE-3. Messenger
ibonucleic acid (mRNA) for caspase-3 was 8.5-fold up-
egulated in HHM, and the protein content was 1.4-fold
igure 4. Proteasome subunit 20S 5 (green). Counterstain for actin is re
re labeled for 20S 5. (B) Comparison with the nuclear stain TOTO
yocardium. (C) Only few structures are labeled for 20S 5. (D) TOTO
igure 5. Apoptosis by the TUNEL method (green). Myocytes are red
Rphalloidin), and nuclei are blue (TOTO). Bar  20 m.ncreased. Cleaved caspase-3 was detected by Western blot
nalysis, but it was absent in controls (Figs. 6 and 7).
CL-2. Bcl-2 gene expression and protein content was three-
o fourfold downregulated (Figs. 6 and 7).
AX. A three- to fourfold increase in gene expression and
rotein content was found (Figs. 6 and 7).
CL-XL. The bcl-xL mRNA was 3.3-fold reduced in HHM,
ut the protein content remained unaltered compared with
ontrol myocardium (Figs. 6 and 7).
-MYC. The mRNA and protein levels for c-myc were un-
hanged in HHM and normal myocardium (Figs. 6 and 7).
53. No significant difference in protein quantity was found
etween HHM and control myocardium. Gene expression,
owever, was downregulated (Figs. 6 and 7).
ISCUSSION
yocyte degeneration, including a loss of myofilaments and
uclear abnormalities, and replacement fibrosis are common
henomena in HHM in contrast to normal myocardium.
lei are blue (TOTO). (A, B) Normal myocardium. (A) Numerous nuclei
rms that the labeled structures are nuclei. (C, D) Human hibernating
s that a great number of nuclei are not stained for 20S 5. Bar  20 m.d; nuc
confi
revealecently, in an animal study of hibernation, structural
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June 16, 2004:2191–9 Cell Death in HHMlterations such as myolysis and increased intracellular
lycogen content were detected in hibernating areas and in
ormally perfused myocardium representing an intra-
ndividual control. It was concluded that the process of
lobal myolysis is caused by chronic elevation in preload or
tretch (11). These results cannot be confirmed by the
resent study. Furthermore, intra-individual control biop-
ies from patients with HHM showed morphologic changes
imilar to those observed in myocardium of nontransplanted
onor hearts; changes in HHM biopsies were always sig-
ificantly more severe than in control region (E. R.
chwarz, unpublished data, 2001). Removal of intra-
ndividual control biopsies was not permitted in the present
tudy.
The histologic and molecular biologic data of the current
tudy revealed the presence of two distinct types of cell
eath in HHM: ubiquitin-related autophagic cell death and
poptosis.
utophagic cell death and the ubiquitin-proteasome
ystem. The ubiquitin-proteasome system represents quan-
itatively the most important process responsible for turn-
ver and destruction of proteins and organelles in several
igure 6. Polymerase chain reaction analysis. (A) Representative original
ecordings. (B) Quantitative evaluation of changes in gene expression. *p
.05 human hibernating myocardium (HHM) versus control. MRNA 
essenger ribonucleic acid.issues. In addition, autophagy plays a major role (12,13). dThe process of autophagy is characterized by different
teps: cellular material is enclosed in double membrane
acuoles (autophagosomes) that subsequently dock to and
use with lysosomes and are digested by lysosomal proteases.
n a final step, fragments of myocytes elicit an extracellular
esponse resulting in phagocytosis of cellular debris by
acrophages and generation of replacement fibrosis
12,14).
In addition to lysosomal enzymes, autophagic cell death
ay involve the ubiquitin/proteasome system as well.
hereas autophagocytosis is random protein degradation,
he ubiquitin-mediated proteolytic pathway is responsible
or a highly selective turnover of intracellular proteins
13,15). However, failure to eliminate ubiquinated proteins
isrupts cellular homeostasis and causes degeneration, fi-
ally resulting in cell death (13,16). Autophagic processes
an lead to cell death, but they are also able to ensure
urvival of cells by elimination of damaging substrates.
The ubiquitin/proteasome system is composed of activat-
ng (E1), conjugating (E2), and ligating (E3) enzymes, as
ell as of the 26S proteasome multi-catalytic proteinase
omplex. Polyubiquinated proteins are targets for ATP-
igure 7. Western blot analysis. (A) Representative examples of original
lots. (B) Quantitative data. *p  0.05 human hibernating myocardium
HHM) versus control.ependent degradation by proteasomes in the nucleus and
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Cell Death in HHM June 16, 2004:2191–9ytoplasm (8,17). In HHM, the percentage of myocytes
xhibiting cellular degeneration, including the occurrence of
utophagic vacuoles, was at a mean value of 18%. The
umber of ubiquitin-positive cells appears exceedingly low.
his, however, has to be considered as a static value
btained at a certain point in time. When calculated for a
onger time period, such as one year, it becomes apparent
hat a significant number of myocytes have been lost from
HM.
Myocytes with large cytoplasmic ubiquitin-protein com-
lexes that showed an absence of nuclear material were
onsidered to be dead cells where transcription and trans-
ation are arrested and the cell will be removed from the
issue (7).
The proteasome content of the myocytes containing
utophagic vacuoles was reduced by 50%, resulting in an
ccumulation of ubiquitin-protein complexes.
Recently, our group described the occurrence of auto-
hagic cell death in myocardium from two different groups
f patients: one with end-stage heart failure due to dilated
ardiomyopathy and another with hypertrophy in transition
o heart failure (7,18). One of the major findings explaining
he mechanism of accumulation of ubiquitin-protein com-
lexes was a significant increase of the conjugating enzyme
2 and a significant reduction of the cleaving enzyme
sopeptidase (7). Unfortunately, the small amount of tissue
erived from the HHM biopsies did not allow for an
xtensive Western blot analysis in order to clarify the
rimary defect in the proteasomal system, which will be the
ubject of future studies.
The time needed for the completion of autophagic cell
eath is not known at the present time, and therefore, it is
ifficult to put into perspective the rate of ubiquitin-positive
ells reported here. Because autophagic cell death is the
esult of chronic degeneration, it may be a slow process
aking days, weeks, or even months to finally kill the cell
17). Experimental studies using cell culture models are
eeded to clarify this issue.
poptotic cell death. The specificity of the TUNEL
ethod has been questioned: labeled cells might be apopto-
ic or oncotic or undergoing DNA repair (19,20). There-
ore, a detailed evaluation of the different steps of the
poptotic cascade is needed to identify the endangerment of
issue by apoptosis.
It was shown here that the apoptotic cascade is activated
n HHM by bcl-2–related apoptosis regulators and by
aspase-3.
In HHM, the gene expression of the anti-apoptotic
actors bcl-2 and bcl-xL was significantly reduced compared
ith control myocardium. The same was true for the bcl-2
rotein content. However, the mRNA and protein content
f the pro-apoptotic molecule bax was increased, whereas
he bax gene transcription factor p53 was unaltered. In
HM, apoptotic cell death seems to be independent of p53.
ifferent models of cardiac myocyte apoptosis in culturehowed that hypoxia acidosis, extracellular lactic acid, reoxy- (enation, and reperfusion are strong stimuli for pro-
rammed cell death that is substantially independent of p53.
hese results were reproduced in p53 knockout mice (21).
n HHM, a normal protein content of p53 was docu-
ented, whereas mRNA was reduced. The half-life time of
he p53 protein might be rather long, so that the protein
evel is still normal in the presence of a reduced mRNA
evel. As published recently, pH is reduced significantly in
HM and could be an apoptotic trigger (22).
The bax/bcl-2 ratio was elevated, indicating an activation
f the death program, which may lead to bax-dependent
itochondrial membrane permeability changes with a loss
f membrane potential and cytochrome c release. Subse-
uently, cytosolic cytochrome c activates a downstream
aspase program (23,24). In HHM, the gene expression of
aspase-3 was upregulated and the protein content twofold
ncreased compared with control myocardium. Further-
ore, cleavage of caspase-3 was evident.
Our observations are, at first sight, contradictory to those
y the group of Borgers (25). However, the lack of apoptotic
ignals may be due to methodologic differences, inhomoge-
eity of the tissue, or selection of the study population. This
roup investigated functional hibernation (i.e., dysfunc-
ional but recoverable myocardium at unimpaired resting
lood flow); our results rather reflect structural hibernation,
s also confirmed by an increased degree of fibrosis. There-
ore, both concepts—dedifferentiation or degeneration with
eplacement fibrosis and cell death—complement each
ther with regard to the current model for the pathophys-
ology of HHM.
ell death in HHM. In HHM, both types of programmed
ell death were found to occur concurrently. In all biopsies,
he mitochondria-dependent apoptotic pathway, with pre-
ominance of pro-apoptotic factors, was activated, but
poptotic nuclear profiles were found only at a very low
umber. This is similar to findings reported by Narula et al.
23) and might have been caused by an extremely rapid
emoval of dead cells by macrophages (26).
Ubiquitin-related autophagic cell death, as documented
n all biopsies, is a consequence of disturbed protein ho-
eostasis (4). However, at the present time, it is difficult to
stimate what percentage of myocytes will die in a given
eriod, because the duration of both events—autophagic
nd apoptotic cell death—is still unknown. Therefore, it
eems preferable to state that myocytes will be lost from the
issue due to both mechanisms of cell death.
On the basis of the present study and previous investiga-
ions, it is proposed that ubiquitin-related autophagic cell
eath is not only occurring in brain tissue but also in cardiac
yocytes (6,8).
Various proteins have been described that are subject to
egulation by proteasomal degradation and play a functional
ole in apoptosis. These include the tumor suppressor gene
53, proto-oncogene c-myc, transcription factor c-fos, and
ax, one of the pro-apoptotic members of the bcl-2 family
15,27,28). Activated caspase-3 can inhibit proteasome
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June 16, 2004:2191–9 Cell Death in HHMunction, and this is followed by an increase in intracellular
biquitin conjugates (29,30). In HHM, the occurrence of
yelin bodies and vacuolar structures represents damaged
roteins, which are ubiquinated but not degraded and form
ntracellular aggregates, as described for neurodegenerative
ituations (8,27). Furthermore, the accumulation of
biquinated proteins might inhibit the ubiquitin/
roteasome system, thereby triggering the autophagic re-
ponse and might act as a signal for activating the apoptotic
ascade in HHM (17). Ultrastructural evidence for cellular
egeneration as mitotic figures was not found. About 0.01%
f myocytes from both hibernating areas and control tissue
howed positive labeling with the cell cycle-associated
uclear nonhistone Ki-67, which is expressed in all active
hases of the cell cycle, but not in quiescent G0 cells. It is
ore abundant in DNA synthesis and mitosis, but it might
lso be observed when DNA synthesis is inhibited (18).
ere, it was interpreted as indicating DNA replication and
epair, as described in a previous report (18).
The clinical consequence of the processes described here
s the persistent danger of irreversible tissue deterioration in
HM, with incomplete functional recovery after revascu-
arization. Intracellular degeneration and loss of myocytes
y apoptosis and autophagy lead to progressive synthesis of
eplacement fibrosis, which determines the functional ca-
acity of the myocardium. As described recently, a rate of
brosis above 32% represents the limit for complete func-
ional recovery after revascularization (4). Therefore, resto-
ation of perfusion at an early time point of the disease is a
ecisive factor, which will determine the clinical outcome of
atients with HHM.
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